Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass Balance and Biotransformation of [14C]HSK3486 in Healthy Chinese Males
NCT03751956Phase 1Completed
- Sponsor
- Sichuan Haisco Pharmaceutical Co., Ltd.
- Start
- Jan 2019
- Primary completion
- Feb 2019
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ciprofol, sponsored by Sichuan Haisco Pharmaceutical Co., Ltd. Primary endpoints: Percentage of cumulative drug excretion of [14C]HSK3486 at 168 hours, Maximum Plasma Concentration at 168 hours and 4 more. Started Jan 2019; status: completed.
02
Drugs
ciprofol
Beyond the preview
Go deeper on NCT03751956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03751956.